|
Jonathan Adereth has served as a Director and strategic consultant to the Company since July 2000. Mr. Adereth was CEO and President of Elscint Ltd., a NYSE medical imaging company, from 1994 until 1998, having served that firm since 1972 in progressively more responsible positions. In 1998 the assets of Elscint were sold to Marconi Medical Inc. and to GE Medical Systems. Mr. Adereth is currently a partner of InnoMed Venture Capital, a member of the Jerusalem Global Ventures, Chairman of the Board and CEO of Carmel Biosensors Ltd. and a Director at Medivision - Ophthalmic Imaging Systems Ltd. and at Eliav - Oncology Imaging Systems Ltd. He is also active in Techbridge Medical Ltd., Ultraguide Ltd. and Smartlight Ltd.
| 